MCM
PFE icon

MAI Capital Management’s Pfizer PFE Stock Holding History

MAI Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-316
Closed -$11K – 598
2019
Q3 		$11K Buy
+316
New +$11.5K ﹤0.01% 524

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

MAI Capital Management's PFE Position: Q1 2026 in Review

MAI Capital Management increased its Pfizer (PFE) stake by 3.5% in Q1 2026, buying an estimated $374K and bringing the position to 420,692 shares worth $11.8M. The position accounts for 0.07% of the portfolio, ranked #253.

MAI Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $36.6M in Q4 2024. 2,940 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • MAI Capital Management held 420,692 shares of Pfizer worth $11.8M as of Q1 2026.
  • MAI Capital Management bought 14,038 Pfizer shares in Q1 2026, an estimated $374K.
  • Pfizer made up 0.07% of MAI Capital Management's portfolio in Q1 2026, its #253 holding.
  • MAI Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • MAI Capital Management's Pfizer position peaked at $36.6M in Q4 2024.
  • 2,940 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.